Practical Guidelines for Managing Patients With Psoriasis on Biologics: An Update

Journal of Cutaneous Medicine and Surgery
Susan M PoelmanAndrei I Metelitsa

Abstract

The paradigm for treating inflammatory diseases has shifted dramatically in the past 10 to 20 years with the discovery of targeted therapeutics or "biologic" agents. Patients with rheumatoid arthritis, inflammatory bowel disease, psoriatic arthritis, and psoriasis, among others, are reaping the benefits of decades of bench to bedside research, allowing them to live more productive lives with less side effects than traditional systemic therapies. Despite these advances, many physicians unfamiliar with biologics are left to care for the basic needs of these patients and may be unaware of the multisystem comorbidities associated with psoriasis and the screening, monitoring, and other special considerations required of biologics patients. This can be overwhelming to primary care physicians and inadvertently expose patients to undue risks. The aim of this review is to provide a practical approach for all health care providers caring for patients with psoriasis being treated with biologics to facilitate communication with their treating dermatologist and ultimately provide patients with more comprehensive care.

References

Apr 1, 1990·British Medical Bulletin·N McIntyre
Aug 25, 1999·Journal of the American Academy of Dermatology·S R RappD M Reboussin
Feb 26, 2000·The Journal of Investigative Dermatology·A Hannuksela-SvahnJ Karvonen
Nov 18, 2003·Clinical and Experimental Dermatology·V J SwaleM H A Rustin
Apr 20, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Jonathan MerminUNKNOWN Emerging Infections Program FoodNet Working Group
May 6, 2004·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·R S WallisD O Beenhouwer
Jan 8, 2005·Rheumatology·J LedinghamUNKNOWN British Society for Rheumatology Standards, Guidelines and Audit Working Group
May 10, 2006·Clinical and Experimental Dermatology·S WahieN J Reynolds
Jun 3, 2006·The Journal of Investigative Dermatology·Joel M GelfandAndrea B Troxel
Oct 13, 2006·JAMA : the Journal of the American Medical Association·Joel M GelfandAndrea B Troxel
Oct 21, 2006·Journal of the American Academy of Dermatology·Andrea L NeimannJoel M Gelfand
Oct 28, 2006·Seminars in Arthritis and Rheumatism·Slim LassouedThierry Billey
Jan 6, 2007·Seminars in Arthritis and Rheumatism·Herwig PieringerGeorg Biesenbach
Jul 17, 2007·Medicine·Manuel Ramos-CasalsMunther A Khamashta
Oct 6, 2007·Clinical Immunology : the Official Journal of the Clinical Immunology Society·Maida WongRam Raj Singh
Dec 15, 2007·Annals of the Rheumatic Diseases·E J CepedaJ D Reveille
Dec 19, 2007·Archives of Dermatology·Joel M GelfandBrian L Strom
Jul 24, 2008·The Journal of Dermatological Treatment·Rieke J B DriessenElke M G J De Jong
May 22, 2009·The Journal of Investigative Dermatology·Joel M GelfandAndrea B Troxel
Jun 17, 2009·Archives of Dermatology·Srjdan ProdanovichDaniel G Federman
Aug 29, 2009·Journal of the European Academy of Dermatology and Venereology : JEADV·D PathiranaB Rzany
Jan 28, 2010·The American Journal of Gastroenterology·Sharmeel K WasanFrancis A Farraye
Jul 2, 2010·Rheumatology·Jean-François RahierFilip De Keyser

❮ Previous
Next ❯

Citations

Aug 11, 2019·The British Journal of Dermatology·W Haidari, S R Feldman
Oct 31, 2019·The Journal of Dermatological Treatment·Derek NiePeter A Lio
Mar 9, 2020·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Ayman A Al HayekMohamed A Al Dawish
Dec 20, 2020·Vaccines·Andrea ChiricozziGiampiero Girolomoni
Jan 23, 2021·Journal of the American Academy of Dermatology·Louise M GreshamMark G Kirchhof
Jul 22, 2021·The Journal of Dermatological Treatment·Mohammad Ibrahim Ahmad FataniMaysa Tariq Yousef Eshmawi

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.